“Ireland is on a fantastic trajectory in terms of our innovative output and the quality of Irish science." Professor Mark Ferguson, Science…

“Cloud-based technology, mobile enablement and fees for service models will lead to faster deployment and increased benefits for patients. Perhaps…

Ger Brennan, MD (Human Health) of MSD Ireland, highlights his mandate to position MSD for success in an evolving healthcare landscape, the…

The CEO of CzechInvest elaborates on the significance of the healthcare and life science industry for the Czech Republic’s transition into an…

The CEO of MSD Italy discusses the company’s promising pipeline, its plans to realize growth through the launch of innovative new drugs in 2016, the…

The Managing Director of MSD Egypt highlights MSD’s unique incentives to further collaborate with the Egyptian medical community and explains how…

Mr Martinez, President of Santen France, reveals how Santen's decision to acquire the French pharmaceutical company Novagali in 2011, was based on…

The managing director of MSD in Mexico explains why the Mexican pharmaceutical market is an attractive market in which to compete, but not one that…

MSD Turkey has benefited in recent years from the ability to engage in local business development initiatives, and managing director Hatice Demiray…

Andrew Wirths arrived to Puerto Rico in 2013 to run Merck’s manufacturing operations on the island. He discusses how dynamic changes within the…

One of the so-called ‘new generation’ of pharmaceutical GMs in Romania outlines his first impressions of the local market and details how MSD has…

Guillermo Browne, Managing Director of MSD Peru, talks about the turnover of the affiliate and the company’s success in bringing new innovation to…